 - Patients of child-bearing potential must agree to use adequate contraceptive methods e.g., hormonal or barrier method of birth control; abstinence prior to study entry and, until at least 3 months after the last dose of the study drug; should a woman become pregnant or suspect she is pregnant while she or her partner is participating in this study, she should inform her treating physician immediately 